169 related articles for article (PubMed ID: 26133490)
1. Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance.
Vesci L; Carollo V; Roscilli G; Aurisicchio L; Ferrara FF; Spagnoli L; De Santis R
Oncol Rep; 2015 Sep; 34(3):1146-52. PubMed ID: 26133490
[TBL] [Abstract][Full Text] [Related]
2. Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.
Lim CY; Chang JH; Lee WS; Lee KM; Yoon YC; Kim J; Park IY
Pancreatology; 2018 Dec; 18(8):913-927. PubMed ID: 30292644
[TBL] [Abstract][Full Text] [Related]
3. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
[TBL] [Abstract][Full Text] [Related]
4. Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy.
Awasthi N; Schwarz MA; Schwarz RE
Cancer Chemother Pharmacol; 2011 Sep; 68(3):571-82. PubMed ID: 21110024
[TBL] [Abstract][Full Text] [Related]
5. Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model.
Wu H; Xin Y; Zhao J; Sun D; Li W; Hu Y; Wang S
Cancer Chemother Pharmacol; 2011 Oct; 68(4):879-87. PubMed ID: 21290245
[TBL] [Abstract][Full Text] [Related]
6. Can vitamin A modify the activity of docetaxel in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Lemancewicz D; Wolczyński S
Folia Histochem Cytobiol; 2007; 45 Suppl 1():S169-74. PubMed ID: 18292828
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab.
Chen JL; Wang JY; Tsai YF; Lin YH; Tseng LM; Chang WC; King KL; Chen WS; Chiu JH; Shyr YM
Menopause; 2013 Jun; 20(6):646-54. PubMed ID: 23340260
[TBL] [Abstract][Full Text] [Related]
8. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer.
Jiang PD; Zhao YL; Deng XQ; Mao YQ; Shi W; Tang QQ; Li ZG; Zheng YZ; Yang SY; Wei YQ
Biomed Pharmacother; 2010 Nov; 64(9):609-14. PubMed ID: 20888174
[TBL] [Abstract][Full Text] [Related]
9. Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model.
Hendrikx JJ; Lagas JS; Song JY; Rosing H; Schellens JH; Beijnen JH; Rottenberg S; Schinkel AH
Int J Cancer; 2016 Feb; 138(3):758-69. PubMed ID: 26297509
[TBL] [Abstract][Full Text] [Related]
10. Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer.
Liu T; Zhang M; Zhang H; Sun C; Yang X; Deng Y; Ji W
Eur J Pharmacol; 2008 Jun; 587(1-3):78-84. PubMed ID: 18442812
[TBL] [Abstract][Full Text] [Related]
11. GDC-0941, a novel class I selective PI3K inhibitor, enhances the efficacy of docetaxel in human breast cancer models by increasing cell death in vitro and in vivo.
Wallin JJ; Guan J; Prior WW; Lee LB; Berry L; Belmont LD; Koeppen H; Belvin M; Friedman LS; Sampath D
Clin Cancer Res; 2012 Jul; 18(14):3901-11. PubMed ID: 22586300
[TBL] [Abstract][Full Text] [Related]
12. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
Kang HJ; Lee SH; Price JE; Kim LS
Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
[TBL] [Abstract][Full Text] [Related]
13. Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity.
Duong MN; Cleret A; Matera EL; Chettab K; Mathé D; Valsesia-Wittmann S; Clémenceau B; Dumontet C
Breast Cancer Res; 2015 Apr; 17(1):57. PubMed ID: 25908175
[TBL] [Abstract][Full Text] [Related]
14. Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models.
Yoo GH; Subramanian G; Piechocki MP; Ensley JF; Kucuk O; Tulunay OE; Lonardo F; Kim H; Won J; Stevens T; Lin HS
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):735-42. PubMed ID: 18645124
[TBL] [Abstract][Full Text] [Related]
15. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
Jensen LR; Huuse EM; Bathen TF; Goa PE; Bofin AM; Pedersen TB; Lundgren S; Gribbestad IS
NMR Biomed; 2010 Jan; 23(1):56-65. PubMed ID: 19650073
[TBL] [Abstract][Full Text] [Related]
16. Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy.
Fujimoto-Ouchi K; Sekiguchi F; Yamamoto K; Shirane M; Yamashita Y; Mori K
Cancer Chemother Pharmacol; 2010 Jul; 66(2):269-76. PubMed ID: 19904537
[TBL] [Abstract][Full Text] [Related]
17. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
18. Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer models.
Martínez-Pérez C; Ward C; Turnbull AK; Mullen P; Cook G; Meehan J; Jarman EJ; Thomson PI; Campbell CJ; McPhail D; Harrison DJ; Langdon SP
Br J Cancer; 2016 Apr; 114(8):905-16. PubMed ID: 27031849
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligodeoxynucleotide targeting HER2 mRNA sensitized docetaxel in breast cancer treatment.
Sun J; Xu Y; Song S; Wu Z; Duan H
Pharm Biol; 2011 Nov; 49(11):1167-72. PubMed ID: 22014264
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice.
Huang X; Bennett M; Thorpe PE
Cancer Res; 2005 May; 65(10):4408-16. PubMed ID: 15899833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]